{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:49:11Z","timestamp":1789058951037,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004386","name":"University of Malaya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013885","name":"Ministry of Health Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109702","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:43:31Z","timestamp":1772095411000},"page":"109702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel 2-Anilinoquinazoline derivatives as apoptosis-inducing agents in drug-resistant NSCLC cells: Integrating biological and computational evaluation"],"prefix":"10.1016","volume":"174","author":[{"given":"Jeevitha","family":"Sivam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maelinda","family":"Daker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marini","family":"Marzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha Yusuf","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Wei","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarif Mohamed","family":"Sofian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzita Mohd","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ameerullah","family":"Sahudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Ariffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajantha","family":"Sinniah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Norazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Kumayl","family":"Abdulwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109702_bb0005","article-title":"Uniqueness of lung cancer in Southeast Asia","volume":"27","author":"Noronha","year":"2024","journal-title":"The LancetReg. Health - Southeast Asia"},{"key":"10.1016\/j.bioorg.2026.109702_bb0010","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1021\/acs.jmedchem.7b00316","article-title":"Trisubstituted pyridinylimidazoles as potent inhibitors of the clinically resistant L858R\/T790M\/C797S EGFR mutant: targeting of both hydrophobic regions and the phosphate binding site","volume":"60","author":"G\u00fcnther","year":"2017","journal-title":"J.Med.Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0015","doi-asserted-by":"crossref","first-page":"15679","DOI":"10.1021\/acs.jmedchem.2c01041","article-title":"Macrocyclization of quinazoline-based EGFR inhibitors leads to exclusive mutant selectivity for EGFR L858R and Del19","volume":"65","author":"Amrhein","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acsmedchemlett.9b00381","article-title":"Discovery and optimization of dibenzodiazepinones as allosteric mutant-selective EGFR inhibitors","volume":"10","author":"De Clercq","year":"2019","journal-title":"ACS Med.Chem.Lett."},{"key":"10.1016\/j.bioorg.2026.109702_bb0025","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1016\/j.bmc.2017.06.004","article-title":"Synthesis and evaluation of osimertinib derivatives as potent EGFR inhibitors","volume":"25","author":"Gao","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115840","article-title":"Design and synthesis of 4th generation EGFR inhibitors against human triple (Del19\/T790M\/C797S) mutation","volume":"261","author":"Jeon","year":"2023","journal-title":"Eur.J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111888","article-title":"Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R\/T790M\/C797S mutant EGFR tyrosine kinase inhibitors","volume":"186","author":"Lei","year":"2020","journal-title":"Eur.J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0040","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acs.jmedchem.2c00704","article-title":"Discovery of BLU-945, a reversible, potent, and wild-type-sparing next-generation EGFR mutant inhibitor for treatment-resistant non-small-cell lung cancer","volume":"65","author":"Eno","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112781","article-title":"Discovery of potent small molecule PROTACs targeting mutant EGFR","volume":"208","author":"Zhao","year":"2020","journal-title":"Eur.J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2026.109702_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1188652","article-title":"Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A","volume":"11","author":"Chattopadhyay","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.109702_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.2009.00577.x","article-title":"SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt\/FOXO pathway","volume":"159","author":"Xie","year":"2010","journal-title":"Br.J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109702_bb0065","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/14756366.2018.1547286","article-title":"Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents","volume":"34","author":"Eldehna","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Weinberg hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109702_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109702_bb0080","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3390\/genes13122183","article-title":"Mechanisms of EGFR-TKI-induced apoptosis and strategies targeting apoptosis in EGFR-mutated non-small cell lung cancer","volume":"13","author":"Nishihara","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.bioorg.2026.109702_bb0085","article-title":"Targeting mutant EGFR in non-small cell lung cancer in the context of cell adaptation and resistance","volume":"30","author":"Roberts","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.109702_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115626","article-title":"Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: a contemporary perspective of SAR and molecular docking studies","volume":"259","author":"Moradi","year":"2023","journal-title":"Eur.J.Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0095","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1134\/S1070363220120294","article-title":"Synthesis, in vitro antiproliferative activity, and in silico studies of new anilinoquinazoline derivatives as potential antitumour agents","volume":"90","author":"Abdulwahab","year":"2020","journal-title":"Russ.J.Gen.Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-323-91095-8.00005-2","article-title":"Chapter 7 - importance of quinazoline and quinazolinone derivatives in medicinal chemistry","volume":"71","author":"Bhat","year":"2021","journal-title":"Stud.Nat.Prod.Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0105","doi-asserted-by":"crossref","first-page":"13413","DOI":"10.1021\/acs.jmedchem.2c01313","article-title":"Discovery of novel, potent, and selective small-molecule menin\u2013mixed lineage leukemia interaction inhibitors through attempting introduction of hydrophilic groups","volume":"65","author":"Lei","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118135","article-title":"Overcoming EGFR mutation resistance: dual inhibition strategies using TKIs in non-small cell lung cancer therapy","volume":"300","author":"Sivam","year":"2025","journal-title":"Eur.J.Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0115","first-page":"573","article-title":"Product class 13: quinazolines","volume":"16","author":"Kikelj","year":"2004","journal-title":"Sci.Synth."},{"key":"10.1016\/j.bioorg.2026.109702_bb0120","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.3390\/ijms24087408","article-title":"Prenylated flavonoids with selective toxicity against human cancers","volume":"24","author":"Tronina","year":"2023","journal-title":"Int. J.Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109702_bb0125","doi-asserted-by":"crossref","unstructured":"R. Barret, 5 - Importance and evaluation of the polar surface area (PSA and TPSA),Therapeutical Chem. 201889\u201395, doi:https:\/\/doi.org\/10.1016\/B978-1-78548-288-5.50005-6.","DOI":"10.1016\/B978-1-78548-288-5.50005-6"},{"key":"10.1016\/j.bioorg.2026.109702_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.109702_bb0135","first-page":"48","article-title":"Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer","volume":"23","author":"Lu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2026.109702_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114792","article-title":"A novel EGFR inhibitor suppresses survivin expression and tumour growth in human gefitinib-resistant EGFR-wild type and -T790M non-small cell lung cancer","volume":"193","author":"Wang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109702_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1476-5586(04)80051-4","article-title":"Upregulation of survivin in G2\/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis","volume":"6","author":"Chandele","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.bioorg.2026.109702_bb0150","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.cdd.4402134","article-title":"Cleavage, degradation of Claspin during apoptosis by caspases and the proteasome","volume":"14","author":"Semple","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2026.109702_bb0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12885-017-3649-y","article-title":"Clusterin modulates transdifferentiation of non-small-cell lung cancer","volume":"17","author":"Jin","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.109702_bb0160","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.4103\/jcrt.JCRT_1281_20","article-title":"BV6 enhances apoptosis in lung cancer cells by ameliorating caspase expressions through attenuation of XIAP, cIAP-1, and cIAP-2 proteins","volume":"18","author":"Ahmad","year":"2022","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.bioorg.2026.109702_bb0165","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/biom12020322","article-title":"Cytoplasmic and nuclear functions of cIAP1","volume":"12","author":"Zadoroznyj","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109702_bb0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10555-018-9728-y","article-title":"Developing TRAIL\/TRAIL death receptor-based cancer therapies","volume":"37","author":"Yuan","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioorg.2026.109702_bb0175","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/JTO.0b013e318217b6c8","article-title":"The tumour necrosis factor-related apoptosis-inducing ligand and lung cancer: still following the right TRAIL?","volume":"6","author":"McGrath","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bioorg.2026.109702_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cells9010060","article-title":"Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy","volume":"9","author":"Yun","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109702_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.31083\/j.fbl2803056","article-title":"Heat shock proteins in non-small-cell lung cancer\u2014functional mechanism","volume":"28","author":"Zhou","year":"2023","journal-title":"Front.Biosci."},{"key":"10.1016\/j.bioorg.2026.109702_bb0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/cells9030587","article-title":"HSP70 multi-functionality in cancer","volume":"9","author":"Albakova","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109702_bb0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acs.chemrestox.9b00335","article-title":"Use of zebrafish in drug discovery toxicology","volume":"33","author":"Cassar","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109702_bb0200","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-13-0314","article-title":"Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC","volume":"3","author":"Walter","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109702_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129786","article-title":"In-silico studies of the antiproliferative activity of new anilinoquinazoline derivatives against NSCLC cells","volume":"1228","author":"Abdulwahab","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109702_bb0210","doi-asserted-by":"crossref","first-page":"9080","DOI":"10.1021\/acs.jmedchem.6b00995","article-title":"Discovery of a noncovalent, mutant-selective epidermal growth factor receptor inhibitor","volume":"59","author":"Chan","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0215","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational approaches in preclinical studies on drug discovery and development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0220","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2220579","article-title":"Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors","volume":"38","author":"Sobh","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3892\/wasj.2025.328","article-title":"Inhibition of nasopharynx cancer cells by selected flavonoids <em>in vitro<\/em> and molecular docking analysis of BCL-w anti-apoptotic protein","volume":"7","author":"Daker","year":"2025","journal-title":"World Acad. Sci. J."},{"key":"10.1016\/j.bioorg.2026.109702_bb0230","article-title":"Anticancer activity of fused quinazoline-quinazolinone: synthesis, biological evaluations, and computational studies","volume":"1326","author":"Abdulwahab","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109702_bb0235","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3390\/nu12082430","article-title":"Punicalagin regulates apoptosis-autophagy switch via modulation of Annexin A1 in colorectal cancer","volume":"12","author":"Ganesan","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2026.109702_bb0240","series-title":"OECD Guidelines for the Testing of Chemicals 236 - Fish Embryo Acute Toxicity (FET) Test","author":"Busquet","year":"2023"},{"key":"10.1016\/j.bioorg.2026.109702_bb0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimisation, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109702_bb0250","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1021\/acs.jcim.1c00884","article-title":"Discovery of novel epidermal growth factor receptor (EGFR) inhibitors using computational approaches","volume":"62","author":"Huo","year":"2022","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:02:40Z","timestamp":1777464160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"alternative-id":["S0045206826002385"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109702","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 2-Anilinoquinazoline derivatives as apoptosis-inducing agents in drug-resistant NSCLC cells: Integrating biological and computational evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109702"}}